Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-233
Closed -$3.42K 2817
2025
Q3
$3.42K Sell
233
-1
-0.4% -$10 ﹤0.01% 1578
2025
Q2
$2.3K Buy
+234
New +$1.94K ﹤0.01% 1273

Other funds holding ETNB

Essential Partners's ETNB Position: Q4 2025 in Review

Essential Partners sold out of 89bio (ETNB) in Q4 2025, closing a stake of 233 shares — an estimated $3.42K sold.

Essential Partners first reported a position in ETNB in Q2 2025 and held it in 2 quarters. The position peaked at $3.42K in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Essential Partners reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Essential Partners sold 233 89bio shares in Q4 2025, an estimated $3.42K.
  • Essential Partners first reported a position in 89bio in Q2 2025 and held it in 2 quarters.
  • Essential Partners's 89bio position peaked at $3.42K in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Essential Partners's 13F filing for Q4 2025, filed 21 May 2026.